Sphamandla E Mtambo
6PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 29, 2023
Unveiling the Inhibitory Potentials of Peptidomimetic Azanitriles and Pyridyl Esters towards SARS-CoV-2 Main Protease: A Molecular Modelling Investigation.Aganze G Mushebenge, Samuel C Ugbaja, Sphamandla E Mtambo
|Jul 27, 2022
In Silico Drug Repurposing of FDA-Approved Drugs Highlighting Promacta as a Potential Inhibitor of H7N9 Influenza Virus.Sphamandla E Mtambo, Hezekiel M Kumalo
|Jul 27, 2022
Structural Investigations and Binding Mechanisms of Oseltamivir Drug Resistance Conferred by the E119V Mutation in Influenza H7N9 Virus.Samuel C Ugbaja, Sphamandla E Mtambo, Aganze G Mushebenge
|Mar 10, 2022
Impact of the R292K Mutation on Influenza A (H7N9) Virus Resistance towards Peramivir: A Molecular Dynamics Perspective.Sphamandla E Mtambo, Samuel C Ugbaja, Hezekiel M Kumalo
|Mar 10, 2022
Intermolecular Mechanism and Dynamic Investigation of Avian Influenza H7N9 Virus' Susceptibility to E119V-Substituted Peramivir-Neuraminidase Complex.Sphamandla E Mtambo, Samuel C Ugbaja, Aganze G Mushebenge
|Feb 10, 2021
Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor Design.Sphamadla E Mtambo, Daniel G Amoako, Anou M Somboro
Pageof 1
